2017 Part D Potential Exclusion Warning Reports
The 2017 Part D Potential Exclusion Warning reports are now available. Please review and take the appropriate action necessary to address the Prescription Drug Event (PDE) records found in the report as outlined in previously distributed HPMS guidance on the PDE exclusion process [Subject: Updates to the Part D Potential Exclusion Warning Report as of the First Quarter of 2018 – CORRECTION].
In the event you have questions, please contact CSSC Operations at 1-877-534-2772 or by email at csscoperations@palmettogba.com.
Last Updated: 02/07/2018